株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

腎デナベーションデバイス市場 - 成長率、傾向、および予測(2019年 - 2024年)

Renal Denervation Devices Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 871444
出版日 ページ情報 英文 114 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.56円で換算しております。
Back to Top
腎デナベーションデバイス市場 - 成長率、傾向、および予測(2019年 - 2024年) Renal Denervation Devices Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年05月01日 ページ情報: 英文 114 Pages
概要

腎デナベーションデバイス市場の成長の主な要因には、高血圧の罹患率の上昇とこの処置の長期にわたる影響が挙げられます。

当レポートでは腎デナベーションデバイス市場について調査しており、市場概況や成長要因・阻害要因、技術別・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報をまとめています・

目次

第1章 イントロダクション

  • 研究成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場のダイナミクス

  • 市場概況
  • 市場成長要因
    • 高血圧の罹患率の上昇
    • 処置効果の持続性
  • 市場阻害要因
    • 痛みを伴う処置
    • 厳格な承認プロセス
  • ポーターファイブフォース分析
    • 新規参入の脅威
    • バイヤー/消費者の交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 業界の競争

第5章 市場セグメント

  • テクノロジー別
    • 高周波ベース
    • 超音波ベース
    • マイクロインフュージョンベース
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東およびアフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Abbott
    • Ablative Solutions
    • Boston Scientific Corporation
    • CardioSonic
    • Kona Medical
    • Medtronic Plc
    • Mercator MedSystems
    • ReCor Medical
    • Symple Surgical

第7章 市場機会および今後の動向

目次
Product Code: 57103

Market Overview

The major factors for the growth of the renal denervation devices market include the rising prevalence of hypertension and the long-lasting effect of the procedure.

High blood pressure is called hypertension. The prevalence of hypertension has observed a significant rise over the past few years. Generally, blood pressure rises and falls throughout the day, but it can damage one's heart and result in health problems if hypertension stays high for a long time. According to the CDC (Centers for Disease Control and Prevention), about 75 million American adults (32%) have high blood pressure (hypertension), but only about half (54%) of them with high blood pressure have their condition under control. High blood pressure was a primary and contributing cause of death for more than 410,000 Americans, in 2014. CDC also states that high blood pressure costs the nation USD 48.6 billion every year. The high prevalence is not just limited to the United States, owing to the fact that Europe and South Asian countries also have a high rate of hypertension makes this a global problem. On the other hand, only a few renal denervation devices are approved in Europe, while the major players are gaining approval for the clinical trials from the FDA in the United States. Thus, owing to the all above-mentioned factors the market is expected to witness high growth in the next coming years.

Scope of the Report

As per the scope of this report, renal denervation devices are one of several innovative device-based interventional therapies, which helps to control blood pressure. It is safe, minimally invasive, and it does not leave any implants behind. The market is segmented by technology and geography.

Key Market Trends

Ultrasound-Based is the Segment by Technology is expected to be the Fastest Growing Segment

The ultrasound-based renal denervation devices is a minimally invasive procedure using ultrasound to ablate nerves in the wall of the renal arteries and it disrupts the transmission of nerve impulses to and from the kidney and lowers blood pressure. Furthermore, according to the first randomized trial to compare the techniques (RADIO SOUND-HTN trial), the ultrasound-based renal denervation (RDN) approach led to greater reductions in the blood pressure than radiofrequency ablation in patients with resistant hypertension. The rising prevalence of hypertension is expected to boost the overall growth of the market.

Europe is Expected to Dominate the Market

Europe is found to hold a major share for the renal denervation devices market and is expected to show a similar trend over the forecast period, without significant fluctuations. According to the data published by Public Health England, high blood pressure affects more than 1 in 4 adults in England. There is a number of renal denervation devices who have received CE approval in Europe. The major factor driving the growth of the market is rising R&D activities for the development of efficient devices. As per the clinicaltrials.gov, one of the market player Abbott Medical Devices has completed the observational study of the EnligHTN renal denervation system in Europe in February 2019. Furthermore, rising cases of drug-resistant hypertension will boost the overall growth of the market over the forecast period.

Competitive Landscape

The market studied is a consolidated market owing to the presence of the few major market players. Some of the market players are Abbott, Ablative Solutions, Boston Scientific Corporation, CardioSonic, Kona Medical, Medtronic Plc, Mercator MedSystems, ReCor Medical, and Symple Surgical

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Hypertension
    • 4.2.2 Long Lasting Effect of the Procedure
  • 4.3 Market Restraints
    • 4.3.1 Painful procedure
    • 4.3.2 Stringent Approval Process for Renal Denervation Devices
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Technology
    • 5.1.1 Radiofrequency Based
    • 5.1.2 Ultrasound Based
    • 5.1.3 Micro-Infusion Based
  • 5.2 Geography
    • 5.2.1 North America
      • 5.2.1.1 US
      • 5.2.1.2 Canada
      • 5.2.1.3 Mexico
    • 5.2.2 Europe
      • 5.2.2.1 Germany
      • 5.2.2.2 UK
      • 5.2.2.3 France
      • 5.2.2.4 Italy
      • 5.2.2.5 Spain
      • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia Pacific
      • 5.2.3.1 China
      • 5.2.3.2 Japan
      • 5.2.3.3 India
      • 5.2.3.4 Australia
      • 5.2.3.5 South Korea
      • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Middle East and Africa
      • 5.2.4.1 GCC
      • 5.2.4.2 South Africa
      • 5.2.4.3 Rest of Middle East and Africa
    • 5.2.5 South America
      • 5.2.5.1 Brazil
      • 5.2.5.2 Argentina
      • 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott
    • 6.1.2 Ablative Solutions
    • 6.1.3 Boston Scientific Corporation
    • 6.1.4 CardioSonic
    • 6.1.5 Kona Medical
    • 6.1.6 Medtronic Plc
    • 6.1.7 Mercator MedSystems
    • 6.1.8 ReCor Medical
    • 6.1.9 Symple Surgical

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top